You are here: All Products  > InnoCare Launches Early Access to CD19 Immunotherapy in China for B-cell Lymphoma

InnoCare Launches Early Access to CD19 Immunotherapy in China for B-cell Lymphoma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products